Current Report Filing (8-k)
September 03 2019 - 3:48PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): August 20, 2019
Natur
International Corp.
(Exact
name of registrant as specified in its charter)
Wyoming
|
|
000-54917
|
|
45-5547692
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
Jachthavenweg
124
1081
KJ Amsterdam
The
Netherlands
|
|
N/A
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: +31 20 578 7700
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company
☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Securities
registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name on exchange on which registered
|
None
|
|
-
|
|
-
|
Item
5.02 - Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers, Compensation Arrangements
of Certain Officers
On
August 20, 2019, Mr. Mark Simmonds accepted a director position on the Board of Directors of Natur International Corp. (“Company”),
pursuant to a proposal to appoint him as a director approved by the Board of Directors on July 8, 2019. Mr. Simmonds will fill
an existing vacancy on the Board of Directors.
Mr.
Simmonds was a Conservative Party politician and Member of Parliament from 2001 to March 2015. He was also a Minister in the UK
Foreign and Commonwealth Office from September 2012 to August 2014. Between 2015-2018, Mr. Simmonds has been a Senior Advisor
to Kroll Inc, since April 2015 he has been the Chairman of the Advisory Board of the Global Investment platform Invest Africa,
from 2015 to 2016 he has been the Chairman of Fincomeco, a company providing business and technological solutions aimed at food
security and economic diversity for Africa and a non-exec director of Bloc Commodities since November 2014 an Advisory Board Member
of the Commonwealth Investment Council, and since 2017 a Board Member of Engender Health, a women’s health organization.
Since 2018 he has also been chairman of GIG technology He became an associate of the Royal Institution of Chartered Surveyors
in 1987. He worked as a surveyor for Savills from 1986 to 1988 and was a partner in Strutt & Parker from 1988 to 1996. He
was a director of Hillier Parker from 1997 to 1999 and a chairman of Mortlock Simmonds Brown from 1999 until becoming an MP.
Mr.
Simmonds will be compensated through an agreement with Mortlock Securities Ltd. under which he will be paid an annual fee of €24,000,
payable monthly, and an additional €1,000 per day for every day that he devotes to preparation for his board duties, up to
a maximum of €15,000 per month. The per diem includes compensation for services as a committee member and working on other
projects or services for the board of directors and Company. The Company has offered to Mr. Simmonds an option grant for the right
to purchase up to 5,816,273 shares of the common stock of the Company, at a purchase price per share of $0.038, vesting in equal
quarterly installments in advance, up to one-third of the total grant per year. This offer is in consideration with Mr. Simmonds
which he may accept at his sole discretion. The agreement provides for Mortlock Securities Ltd. to enter into a shareholder’s
agreement that will provide for transfer restrictions which will include board pre-approval of transfer, automatic dilution, and
tag and drag rights. The agreement provides for Mr. Simmonds not to engage in any business that competes with that of the Company
or own a greater than 5% interest in any competing company.
Item
9.01 - Financial Statements and Exhibits
(d) Exhibits
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Natur
International Corp.
|
|
|
Date:
September 3, 2019
|
By:
|
/s/
Ruud Huisman
|
|
Name:
|
Ruud
Huisman
|
|
Title:
|
Chief
Financial Officer
|
2
Natur (CE) (USOTC:NTRU)
Historical Stock Chart
From Aug 2024 to Sep 2024
Natur (CE) (USOTC:NTRU)
Historical Stock Chart
From Sep 2023 to Sep 2024